- Home
- NPKI vs LIMN Comparison
NPKI vs LIMN Comparison
Compare NPKI & LIMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- LIMN
- Stock Information
- Founded
- NPKI 1932
- LIMN 2018
- Country
- NPKI United States
- LIMN United States
- Employees
- NPKI N/A
- LIMN N/A
- Industry
- NPKI Metal Fabrications
- LIMN
- Sector
- NPKI Industrials
- LIMN
- Exchange
- NPKI Nasdaq
- LIMN NYSE
- Market Cap
- NPKI 722.7M
- LIMN 623.8M
- IPO Year
- NPKI N/A
- LIMN N/A
- Fundamental
- Price
- NPKI $8.55
- LIMN $6.65
- Analyst Decision
- NPKI Strong Buy
- LIMN
- Analyst Count
- NPKI 1
- LIMN 0
- Target Price
- NPKI $12.00
- LIMN N/A
- AVG Volume (30 Days)
- NPKI 819.3K
- LIMN 503.2K
- Earning Date
- NPKI 08-04-2025
- LIMN 01-01-0001
- Dividend Yield
- NPKI N/A
- LIMN N/A
- EPS Growth
- NPKI N/A
- LIMN N/A
- EPS
- NPKI N/A
- LIMN N/A
- Revenue
- NPKI $233,299,000.00
- LIMN N/A
- Revenue This Year
- NPKI $15.28
- LIMN N/A
- Revenue Next Year
- NPKI $9.62
- LIMN N/A
- P/E Ratio
- NPKI $17.54
- LIMN N/A
- Revenue Growth
- NPKI 312.30
- LIMN N/A
- 52 Week Low
- NPKI $4.76
- LIMN $4.40
- 52 Week High
- NPKI $8.88
- LIMN $33.66
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- LIMN N/A
- Support Level
- NPKI N/A
- LIMN N/A
- Resistance Level
- NPKI N/A
- LIMN N/A
- Average True Range (ATR)
- NPKI 0.00
- LIMN 0.00
- MACD
- NPKI 0.00
- LIMN 0.00
- Stochastic Oscillator
- NPKI 0.00
- LIMN 0.00
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.